(NU/1433-40) Transdermal Drug Delivery: The Provision of Business Consultancy to Assist Commercialisation of University Research

A Contract Award Notice
by NEWCASTLE UNIVERSITY

Source
OJEU
Type
Contract (Services)
Duration
not specified
Value
£30K
Sector
BUSINESS
Published
27 Jan 2023
Delivery
not specified
Deadline
n/a

Concepts

Location

Newcastle upon Tyne

Geochart for 7 buyers and 1 suppliers

7 buyers

1 supplier

Description

The Northumbria University team have developed a new technology to move drugs into the body from a layer in a patch stuck to the skin. This is an alternative to using needles. Current drug delivery patches don’t work for a large proportion of drugs because of their chemistry characteristics mean they don’t absorb through skin well. This technology can move ‘difficult’ molecules through the skin. The initial brief of the executive will be to: (1) Produce a viable 5 year business plan; (2) Obtain university approval for the venture; a. Act for the company in the spin-out legal process and address all company formation matters; b. Provide to the appropriate university all matters necessary for Research England reporting requirements; (3) Secure a Medical Device Manufacturer partnership (4) Engage with investors in securing funding

Total Quantity or Scope

Newcastle, Sunderland, Northumbria, Durham, Teesside universities together with the University of Bath on behalf of the SETsquared Partnership (the Enterprise collaboration of the Universities of Bath, Bristol, Exeter, Southampton and Surrey) and any other HE Institution that wishes to join this DPS, as detailed in the Office for Students Register, https://www.officeforstudents.org.uk/advice-and-guidance/the-register/the-ofs-re... will engage suitably qualified and experienced executives through the DPS as and when required over the DPS period. The specific requirements will be detailed in each individual further competition. The typical brief of an executive will be to: (a) Produce a viable business plan; (b) Obtain university approval for the venture; (c) Act for the company in the spin-out legal process and address all company formation matters; (d) Provide to the appropriate university all matters necessary for Research England and ESIF reporting requirements; (e) Secure (venture capital and/or other) funding in accordance with the business plan. This will be a cyclical process throughout the entire Research England, and potential ESIF project along with any additional funding streams.

Award Detail

1 DR Peter Arnold (Northumberland)
  • Transdermal Drug Delivery: The Provision of Business Consultancy to Assist Commercialisation of University Research
  • Reference: (nu/1433-40)
  • Num offers: 3
  • Value: £30,000
  • Contractor is an SME.

Award Criteria

Ability to meet the required programme _
Quality: Ability to meet the Job Description 60.0
Equity share 15.0
PRICE 25.0

CPV Codes

  • 79410000 - Business and management consultancy services

Indicators

  • Award on basis of price and quality.

Other Information

This an award from a DPS framework there was no pin and the contract notice was for the overall DPS itself. Overall Official Journal reference for the overall DPS is OJ S: 2022/S 186-528050

Reference

Domains